Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.